{"id":1005,"date":"2017-02-17T08:22:41","date_gmt":"2017-02-17T07:22:41","guid":{"rendered":"https:\/\/site.uit.no\/trec\/?p=1005"},"modified":"2017-02-17T15:47:35","modified_gmt":"2017-02-17T14:47:35","slug":"endelig-klart-for-vinterens-trec-seminar","status":"publish","type":"post","link":"https:\/\/site.uit.no\/trec\/2017\/02\/17\/endelig-klart-for-vinterens-trec-seminar\/","title":{"rendered":"Endelig klart for vinterens TREC-seminar"},"content":{"rendered":"

Det er tid for TRECs halv\u00e5rlige forskningsseminar, som denne gangen finner sted p\u00e5<\/p>\n

<\/a>

Fra fjor\u00e5rets vinter-TREC-seminar som ble avholdt p\u00e5 Sommar\u00f8y.<\/p><\/div>\n

Linken p\u00e5 Forskningsparken i Troms\u00f8, like ved Universitetet i Troms\u00f8 – Norges arktiske universitet (UiT).\u00a0Det blir en dag<\/p>\n

proppet med nettopp det vi i TREC forsker p\u00e5 – blodpropp. Se program for dagen nederst i saken!<\/p>\n

– Alle medarbeidere i TREC presenterer sine forel\u00f8pige forskningsresultater og f\u00e5r innspill fra andre forskere. Det har vi gjort to ganger i \u00e5ret siden starten av 2000-tallet, s\u00e5 dette er en veletablert tradisjon, sier professor John-Bjarne Hansen, som er leder ved K.G. Jebsen TREC – senter for tromboseforskning.<\/p>\n

En av\u00a0hensiktene\u00a0med TREC-seminarene er at unge forskere som er p\u00e5 starten av sin karriere skal f\u00e5 mulighet til \u00e5 legge frem\u00a0forskningen sin og diskutere resultatene med andre kompetente forskere og kolleger. Det \u00e5 kunne diskutere egen forskning f\u00f8r den er ferdig er et viktig moment for \u00e5 fobredre forskningsproduktet.<\/p>\n

– I tillegg gir det god presentasjonstrening. Det \u00e5 tilbringe dagen sammen utenfor kontoret og s\u00e5 avslutte med en hyggelig middag er ogs\u00e5 en viktig del av det hele. Det er med p\u00e5 \u00e5 skape identitet og sosial tilh\u00f8righet, forteller Hansen.<\/p>\n

F\u00f8lg med p\u00e5 bloggen og p\u00e5 sosiale medier for spennende oppdateringer fra dagens TREC-seminar!<\/p>\n

 <\/p>\n

Program for the winter seminar, Friday 17th<\/sup> of February <\/u><\/strong><\/p>\n

08:30-09:00 \u00a0 \u00a0TREC status and challenges in 2017 (John-Bjarne Hansen)<\/p>\n

09:00-09:15\u00a0\u00a0\u00a0 Coffee break<\/strong><\/p>\n

Case-crossover studies in venous thrombosis<\/em><\/p>\n

09:15-09:35\u00a0\u00a0\u00a0 The case-crossover design – possibilities and limitations (Sigrid K. Br\u00e6kkan)<\/p>\n

09:35-09:55\u00a0\u00a0\u00a0 Impact of triggers on risk of VTE in cancer (Olga Vikhammer Gran)<\/p>\n

09:55-10:15\u00a0\u00a0\u00a0 Impact of triggers on VTE risk in subjects hospitalized for acute infections (Gro Grimnes)<\/p>\n

10:15-10:35\u00a0\u00a0\u00a0 Differential impact of surgery as trigger of incident VTE in patients with and without pro-thrombotic genotypes (Esben Bj\u00f8ri)<\/p>\n

10:35-10:45\u00a0\u00a0\u00a0 Coffee refill<\/strong><\/p>\n

Immunothrombosis<\/em><\/p>\n

10:45-11:05\u00a0\u00a0\u00a0 Short-chain Poly-P and complement activation in plasma and whole blood systems (Ina H\u00f8iland)<\/p>\n

11:05-11:25\u00a0\u00a0\u00a0 Extracellular vesicles and complement activation in human plasma (Robin Liang)<\/p>\n

11:25-11:45\u00a0\u00a0\u00a0 The role of complement in tissue factor-upregulation and coagulation activation in human whole blood (Ole Lars Brekke)<\/p>\n

11:45-12:05\u00a0\u00a0\u00a0 Short-chain Poly-P and coagulation activation in whole blood (Ina H\u00f8iland)<\/p>\n

12:10-13:00\u00a0\u00a0\u00a0 Lunch<\/strong><\/p>\n

Life-style and venous thrombosis<\/em><\/p>\n

13:00-13:20\u00a0\u00a0\u00a0\u00a0 Regular physical activity and risk of VTE recurrence and mortality (Line H. Evensen)<\/p>\n

13:20-13:40\u00a0\u00a0\u00a0\u00a0 Fish intake and risk of VTE recurrence and mortality (Trond Isaksen)<\/p>\n

13:40-14:00\u00a0\u00a0\u00a0\u00a0 MI-related first VTE and risk of VTE recurrence (Nadia Arshad)<\/p>\n

14:00-14:20\u00a0\u00a0\u00a0\u00a0 Regular physical activity and risk of cancer-related VTE (Line H. Evensen)<\/p>\n

14:20-14:50\u00a0\u00a0\u00a0 Coffee break<\/strong><\/p>\n

Plasma biomarkers and prediction of venous thrombosis<\/em><\/p>\n

14:50-15:30\u00a0\u00a0\u00a0\u00a0 Plasma proteomics and risk of VTE (Kristian Hindberg and S\u00f8ren B. Jensen)<\/p>\n

15:30-15:50\u00a0\u00a0\u00a0\u00a0 Plasma expression of miRNAs and risk of VTE (Irina Starikova)<\/p>\n

15:50-16:10\u00a0\u00a0\u00a0\u00a0 Prediction of PE and stroke by CHAD-Vasc score in AF (Erin M. Hald)<\/p>\n

16:10-16:20\u00a0\u00a0\u00a0 Coffee refill<\/strong><\/p>\n

The adipose tissue and venous thrombosis\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/em><\/p>\n

16:20-16:50\u00a0\u00a0\u00a0\u00a0 The role of adipose tissue in immunothrombosis (Tima Sovershaev)<\/p>\n

16:50-17:10\u00a0\u00a0\u00a0\u00a0 Plasma levels of leptin and the risk of VTE (Lars Horvei)<\/p>\n

17:10-17:20\u00a0\u00a0\u00a0 Concluding remarks<\/strong><\/p>\n

18.00 \u00a0 \u00a0Dinner<\/p>\n